From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

How Long to Take Alendronate for Osteoporosis?

Women at low risk for fracture after 5 years may be able to take a break.

Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially because alendronate is incorporated in bone matrix and has a biological half-life of more than 10 years. In this study, a total of 1099 postmenopausal women (mean age, 73) — who had taken alendronate for at least 5 years in a previous clinical trial — were randomized to continued treatment (either 5 or 10 mg/day) or placebo. All participants also took 500 mg/day of calcium and 250 U/day of vitamin D.

After 5 additional years of follow-up, BMD (total hip, femoral neck, trochanter, or lumbar spine) was roughly 2%–3% greater in both alendronate groups than in the placebo group, although BMD in the placebo group was slightly higher than at the start of the previous trial 10 years earlier. Biochemical markers for bone turnover increased to a statistically greater extent in the placebo group than in either alendronate group. There were no differences between groups in the rate of nonvertebral fractures, but symptomatic vertebral fractures were significantly less common in the alendronate group than in the placebo group (2.4% vs. 5.3%).

Comment: These "glass half-full, half-empty" results suggest that women at low risk for fracture may feel comfortable taking a break after 5 years of alendronate treatment. Other women, particularly those with prior fractures or very low bone density, may choose to continue.

— Thomas L. Schwenk, MD

Published in Journal Watch General Medicine January 9, 2007

Citation(s):

Black DM et al. Effects of continuing or stopping alendronate after 5 years of treatment: The Fracture Intervention Trial Long-term Extension (FLEX): A randomized trial. JAMA 2006 Dec 27; 296:2927-38.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Related Content

Other Perspectives

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2007. Massachusetts Medical Society. All rights reserved.